InMode (INMD) EBIT Margin (2018 - 2026)
InMode (INMD) posted quarterly EBIT Margin of 12.26% for Q1 2026, down 779.0% year-on-year from 1.81% in Q1 2025, and down 51.01% on a QoQ basis from 25.03% in Q4 2025.
InMode (INMD) EBIT Margin (2018 - 2026) Analysis & Trends
InMode (INMD) has reported EBIT Margin for 9 consecutive years, with 12.26% the latest figure, recorded in Q1 2026.
- Quarterly EBIT Margin fell 779.0% year-over-year to 12.26% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 21.31% (down 674.0% YoY) and the FY2025 annual result came in at 23.05%, down 546.0% from the prior year.
- EBIT Margin retreated to 12.26% in Q1 2026 per INMD's latest filing, from 25.03% in the prior quarter.
- Over the last five years, EBIT Margin for INMD reached as high as 44.84% in Q4 2022 and fell as low as 12.26% in Q1 2026.
- A 5-year average of 32.05% and a median of 37.06% in 2024 frame the typical range for EBIT Margin.
- Annual changes were most pronounced in 2024 — EBIT Margin sank 2071 bps — and 2025, when it soared 275 bps.
- Year by year, EBIT Margin stood at 44.84% in 2022, then decreased by 10 bps to 40.42% in 2023, then retreated by 30 bps to 28.48% in 2024, then fell by 12 bps to 25.03% in 2025, then tumbled by 51 bps to 12.26% in 2026.
- According to Business Quant data, EBIT Margin over the past three periods registered 12.26%, 25.03%, and 22.43% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InMode | 956,721.10 | -479.17 Mn | 61.55 Mn | 12.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.26% |
| Dec 31, 2025 | 25.03% |
| Sep 30, 2025 | 22.43% |
| Jun 30, 2025 | 23.93% |
| Mar 31, 2025 | 20.06% |
| Dec 31, 2024 | 28.48% |
| Sep 30, 2024 | 37.06% |
| Jun 30, 2024 | 21.18% |
| Mar 31, 2024 | 22.54% |
| Dec 31, 2023 | 40.42% |
| Sep 30, 2023 | 37.70% |
| Jun 30, 2023 | 41.89% |
| Mar 31, 2023 | 38.65% |
| Dec 31, 2022 | 44.84% |
| Sep 30, 2022 | 44.33% |
| Jun 30, 2022 | 43.33% |
| Mar 31, 2022 | 40.74% |
| Dec 31, 2021 | 48.99% |
| Sep 30, 2021 | 47.80% |
| Jun 30, 2021 | 47.56% |